The Effects of Inclisiran on the Subclinical Inflammatory Markers of Atherosclerotic Cardiovascular Disease in Patients at High Cardiovascular Risk.

Pharmaceuticals (Basel) · 2025 · PMC12196025 · PMID 40573228

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

nearly statistically significantp = 0.053so close (0.05 < p ≤ 0.1)

study group 2: 102 (98.5–106) [mg/dL] ( p = 0.0091), which was associated with a nearly statistically significant difference in the glycated hemoglobin (HbA1c) level: study group 1: 5.58 (5.18–5.7) vs. study group 2: 5.95 (5.61–6.06) [%] ( p = 0.053).

also in 78 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.